Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,694,821 papers from all fields of science
Search
Sign In
Create Free Account
Kv Channel-Interacting Protein 3
Known as:
A Type Potassium Channel Modulatory Protein 3
, KChIP3 Protein
, Calsenilin
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
KCNIP3 gene
Broader (1)
Kv Channel-Interacting Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Inhibition of the Neuronal Calcium Sensor DREAM Modulates Presenilin-2 Endoproteolysis
R. Naranjo
,
Paz González
,
Alejandro López-Hurtado
,
Xosé M. Dopazo
,
B. Mellström
,
J. Naranjo
Frontiers in Molecular Neuroscience
2018
Corpus ID: 54207628
Deregulated intracellular Ca2+ and protein homeostasis underlie synaptic dysfunction and are common features in neurodegenerative…
Expand
2015
2015
Ca2+ and Mg2+ modulate conformational dynamics and stability of downstream regulatory element antagonist modulator
K. Pham
,
Gangadhar Dhulipala
,
+4 authors
J. Miksovska
Protein Science
2015
Corpus ID: 6310377
Downstream Regulatory Element Antagonist Modulator (DREAM) belongs to the family of neuronal calcium sensors (NCS) that transduce…
Expand
Review
2012
Review
2012
Negative modulation of NMDA receptor channel function by DREAM/calsenilin/KChIP3 provides neuroprotection?
KeWei Wang
,
Yun Wang
Frontiers in Molecular Neuroscience
2012
Corpus ID: 13523348
N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels highly permeable to calcium and essential to excitatory…
Expand
2011
2011
Increases in mRNA and DREAM Protein Expression in the Rat Spinal Cord After Formalin Induced Pain
I. Long
,
R. Suppian
,
Z. Ismail
Neurochemical Research
2011
Corpus ID: 33677951
Downstream Regulatory Element Antagonist Modulator (DREAM) protein modulates pain by regulating prodynorphin gene transcription…
Expand
2011
2011
Calsenilin is degraded by the ubiquitin-proteasome pathway.
C. Jang
,
J. Choi
,
+5 authors
E. Choi
Biochemical and Biophysical Research…
2011
Corpus ID: 40345118
2008
2008
Characterization of subcellular localization and Ca2+ modulation of calsenilin/DREAM/KChIP3
H. Woo
,
Jae-Woong Chang
,
Yun-Hyung Choi
,
A. Gwon
,
Yong-Keun Jung
,
D. Jo
NeuroReport
2008
Corpus ID: 20808430
Earlier reports found that calsenilin is a transcriptional repressor or a subunit of plasma membrane channel, and indicated that…
Expand
2008
2008
Distinct Responses of DREAM to Electroacupuncture Stimulation with Different Frequencies During Physiological and Inflammatory Conditions in Rats
Yi Li
,
Ying Zhang
,
Jisheng Han
,
Yun Wang
Neurochemical Research
2008
Corpus ID: 15149789
Our previous results indicated that dynorphin in the spinal dorsal horn mediates the analgesic effect of high frequency…
Expand
2007
2007
Distribution of Downstream Regulatory Element Antagonist Modulator (DREAM) in Rat Spinal Cord and Upregulation of Its Expression during Inflammatory Pain
Ying Zhang
,
Yi Li
,
Yanrui Yang
,
Haihao Zhu
,
Jisheng Han
,
Yun Wang
Neurochemical Research
2007
Corpus ID: 380430
A previous knockout study revealed the critical role of downstream regulatory element antagonist modulator (DREAM) in pain…
Expand
2006
2006
Calsenilin interacts with transcriptional co‐repressor C‐terminal binding protein(s)
N. F. Zaidi
,
Kristy G Kuplast
,
Kevin J. Washicosky
,
Y. Kajiwara
,
J. Buxbaum
,
W. Wasco
Journal of Neurochemistry
2006
Corpus ID: 33227742
Calsenilin/potassium channel‐interacting protein (KChIP)3/ downstream regulatory element sequence antagonist modulator (DREAM) is…
Expand
2002
2002
Molecular cloning and characterization of CALP / KChIP 4 , a novel EF-hand protein interacting with presenilin 2 and voltage-gated potassium channel subunit Kv 4
Y. Morohashi
,
Noriyuki Hatano
,
+6 authors
T. Iwatsubo
2002
Corpus ID: 41254964
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE